Rezolute, Inc.

Rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases.

Otsuka

Silver Member: Otsuka

At Otsuka, our people are passionate about developing and delivering original products as part of a global holistic commitment to better health and well-being.

We have two core businesses dedicated to achieving our goals: a pharmaceutical business and a nutraceutical business. The pharmaceutical business develops and markets products for the diagnosis and treatment of disease in the following areas: central nervous system, oncology, gastroenterology, ophthalmology and cardiovascular. The nutraceutical business is dedicated to maintaining and improving health through the use of foods and […]

AbSci

AbSci’s SoluPro is a proprietary, bioengineered expression platform that allows for easily optimizable and scalable production of complex proteins, including monoclonal antibodies. The core technology allows proteins to be produced at a fraction of the current cost, while maintaining all of their performance characteristics.

AgonOx

AgonOx is focused on the development of immune system modulators in combination with other promising cancer immunotherapies.

Diamond Member: Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen […]

Aronora

Aronora is a translational biotechnology company engaged in the early-stage commercial development of proprietary biologic therapeutics, including recombinant monoclonal antibodies and enzymes.  Building on the company’s ground-breaking rational approaches to superior drug safety, Aronora’s product candidates have the potential to become first-in-class medical emergency therapeutics to treat life-threatening acute thrombotic vascular diseases early, in the field, even before the patient is hospitalized and the diagnosis is verified.

Silver Member: Astellas

At Astellas, we build on our proud specialty heritage to develop innovative products that improve the lives of patients. To achieve this goal, our strategy is to focus on select therapeutic areas in order to develop a deep understanding of specific health conditions and the unique needs of our patients and customers.

In the United States, we concentrate our efforts in the following key therapeutic areas: cardiology, immunology, infectious disease, neuroscience, oncology and urology. We also are expanding our expertise to advancements […]